The belief that smoking marijuana unleashes creativity in some individuals is a myth, based on research conducted in the Netherlands.
Lorenza Colzato, PhD, of Leiden University and colleagues found that the active ingredient in marijuana, THC, actually impairs thinking, based on their study in 54 people.
Participants, who were all regular cannabis users, were divided equally into three groups. One was given highly potent cannabis (highest levels of THC), another was given a less powerful form of the drug and a third group was given placebo.
Participants were asked to complete a variety of tasks to measure convergent and divergent thinking. The former involved asking them to name as many uses for a common household item, such as a pen. The latter asked participants to find an association between three unrelated words.
Overall, participants in the most potent marijuana group fared the worst on the tasks, the researchers reported in the journal Psychopharmacology.
“The frequently reported feeling of heightened creativity could be an illusion,” the researchers wrote. “In other words, smoking a joint may not be the best choice when in need of breaking the ‘writer’s block’ or overcoming other artistic inhibitions, and smoking several of them might actually be counter-productive."
People often think that smoking cannabis makes them more creative. However, research by Leiden University psychologists Lorenza Colzato and Mikael Kowal in the Netherlands shows that the opposite is true. They published their findings in Psychopharmacology.
The findings show that cannabis with a high concentration of the psychoactive ingredient THC does not improve creativity. A high dose of THC was actually shown to have a negative effect on the ability to quickly come up with as many solutions as possible to a given problem.
Enjoying our content?
Thanks for visiting Psychiatry Advisor. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Psychiatry Advisor. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Evidence-Based Guidance
- Conference Coverage
- Unique Psychiatry Case Studies
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.